77 related articles for article (PubMed ID: 21664731)
1. Synthesis and screening of galactose-linked nitroimidazoles and triazoles against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Eur J Med Chem; 2011 Sep; 46(9):4725-32. PubMed ID: 21664731
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents.
Mugunthan G; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Carbohydr Res; 2011 Sep; 346(13):1760-6. PubMed ID: 21714959
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3947-50. PubMed ID: 21641797
[TBL] [Abstract][Full Text] [Related]
4. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
[TBL] [Abstract][Full Text] [Related]
5. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
6. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
8. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles.
Patel NB; Khan IH; Rajani SD
Eur J Med Chem; 2010 Sep; 45(9):4293-9. PubMed ID: 20630629
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1, 3, 4-thiadiazole-2-ylthio)acetates.
Foroumadi A; Soltani F; Moallemzadeh-Haghighi H; Shafiee A
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):112-6. PubMed ID: 15756694
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.
Güzeldemirci NU; Küçükbasmaci O
Eur J Med Chem; 2010 Jan; 45(1):63-8. PubMed ID: 19939519
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of glycal-derived novel tetrahydrofuran 1,2,3-triazoles by 'click' chemistry.
Vijaya Raghava Reddy L; Venkat Reddy P; Mishra NN; Shukla PK; Yadav G; Srivastava R; Shaw AK
Carbohydr Res; 2010 Jul; 345(11):1515-21. PubMed ID: 20478557
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitubercular activity of monocyclic nitroimidazoles: insights from econazole.
Lee SH; Kim S; Yun MH; Lee YS; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2011 Mar; 21(5):1515-8. PubMed ID: 21277200
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Soltani F; Rezaee MA; Moshafi MH
Boll Chim Farm; 2003 Nov; 142(9):416-9. PubMed ID: 14971311
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
[TBL] [Abstract][Full Text] [Related]
17. Targeting tuberculosis through a small focused library of 1,2,3-triazoles.
Labadie GR; de la Iglesia A; Morbidoni HR
Mol Divers; 2011 Nov; 15(4):1017-24. PubMed ID: 21633789
[TBL] [Abstract][Full Text] [Related]
18. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis.
Menendez C; Rodriguez F; Ribeiro AL; Zara F; Frongia C; Lobjois V; Saffon N; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2013 Nov; 69():167-73. PubMed ID: 24016834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
